KalVista Pharmaceuticals (KALV) Reports Q1 Loss of $0.47/Share

KalVista Pharmaceuticals (NASDAQ: KALV) reported Q1 EPS of ($0.47), versus ($0.51) reported last year. Revenue for the quarter came in at $3.7 million, versus $10 thousand reported last year.

For earnings history and earnings-related data on KalVista Pharmaceuticals (KALV) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
• C.H. Robinson acquires DeSpir Logistics for $75 million